DNLI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $4,491,915.99

Denali Therapeutics Insider Trading History Chart

Denali Therapeutics Share Price & Price History

^$14.96

▼ -0.6 (-3.86%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Denali Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/15/2024	Vicki L. Sato	Director	Sell	1,666	$18.29	$30,471.14	118,043
4/1/2024	Steve E Krognes	Director	Sell	92,500	$20.50	$1,896,250.00	47,341
2/15/2024	Vicki L. Sato	Director	Sell	1,666	$18.37	$30,604.42	121,375
2/13/2024	Carole Ho	Insider	Sell	2,784	$17.29	$48,135.36	145,010
2/13/2024	Ryan J Watts	CEO	Sell	9,589	$17.29	$165,793.81	238,067
2/13/2024	Steve E Krognes	Director	Sell	2,750	$17.29	$47,547.50	139,841
1/16/2024	Vicki L. Sato	Director	Sell	1,666	$18.42	$30,687.72	123,041
1/10/2024	Carole Ho	Insider	Sell	4,668	$19.02	$88,785.36	147,794
1/9/2024	Ryan J Watts	CEO	Sell	7,818	$19.78	$154,640.04	2,268,363
1/5/2024	Carole Ho	Insider	Sell	9,972	$19.43	$193,755.96	198,777
1/5/2024	Ryan J Watts	CEO	Sell	17,483	$19.43	$339,694.69	2,276,181
1/5/2024	Steve E Krognes	Director	Sell	3,208	$19.43	$62,331.44	142,591
12/15/2023	Vicki L. Sato	Director	Sell	1,666	$23.39	$38,967.74	124,707
11/15/2023	Vicki L. Sato	Director	Sell	1,666	$19.13	$31,870.58	126,373
10/16/2023	Vicki L. Sato	Director	Sell	1,666	$20.66	$34,419.56	128,039
9/15/2023	Vicki L. Sato	Director	Sell	1,666	$23.62	$39,350.92	129,705
8/23/2023	Carole Ho	Insider	Sell	2,522	$23.22	$58,560.84	182,809
8/21/2023	Carole Ho	Insider	Sell	2,478	$22.60	$56,002.80	185,331
8/21/2023	Carole Ho	Insider	Sell	2,478	$22.60	$56,002.80	185,331
8/21/2023	Ryan J Watts	CEO	Sell	2,309	$22.59	$52,160.31	2,242,604
8/21/2023	Ryan J Watts	CEO	Sell	2,309	$22.59	$52,160.31	2,242,604
8/21/2023	Steve E Krognes	Director	Sell	1,419	$22.60	$32,069.40	145,799
8/21/2023	Steve E Krognes	Director	Sell	1,419	$22.60	$32,069.40	145,799
8/15/2023	Vicki L. Sato	Director	Sell	1,666	$24.30	$40,483.80	131,371
8/14/2023	Carole Ho	Insider	Sell	2,768	$23.79	$65,850.72	182,809
8/10/2023	Carole Ho	Insider	Sell	2,857	$24.15	$68,996.55	185,577
8/10/2023	Ryan J Watts	CEO	Sell	2,526	$25.03	$63,225.78	2,239,913
7/17/2023	Alexander O Schuth	Insider	Sell	10,000	$29.60	$296,000.00	528,691
7/17/2023	Vicki L. Sato	Director	Sell	1,666	$29.60	$49,313.60	133,037
6/28/2023	Vicki L. Sato	Director	Sell	1,666	$29.84	$49,713.44	134,703
5/15/2023	Alexander O Schuth	Insider	Sell	10,000	$28.60	$286,000.00	528,691
4/20/2023	Ryan J Watts	CEO	Sell	200	$25.00	$5,000.00	2,239,913
4/12/2023	Alexander O Schuth	Insider	Sell	5,102	$25.04	$127,754.08	528,691
2/13/2023	Carole Ho	Insider	Sell	2,548	$30.10	$76,694.80	184,285
2/13/2023	Ryan J Watts	CEO	Sell	33,815	$30.08	$1,017,155.20	2,239,913
2/13/2023	Steve E Krognes	Director	Sell	2,119	$30.10	$63,781.90	143,002
2/10/2023	Carole Ho	Insider	Sell	818	$29.80	$24,376.40	179,365
2/10/2023	Ryan J Watts	CEO	Sell	25,000	$29.10	$727,500.00	2,229,031
2/8/2023	Carole Ho	Insider	Sell	1,521	$30.88	$46,968.48	180,183
2/8/2023	Steve E Krognes	Director	Sell	1,377	$30.88	$42,521.76	145,121
1/17/2023	Alexander O Schuth	Insider	Sell	10,000	$29.53	$295,300.00	497,173
1/9/2023	Carole Ho	Insider	Sell	1,459	$28.48	$41,552.32	177,454
1/6/2023	Carole Ho	Insider	Sell	1,451	$28.67	$41,600.17	178,913
1/5/2023	Steve E Krognes	Director	Sell	2,970	$28.44	$84,466.80	146,498
1/4/2023	Carole Ho	Insider	Sell	2,913	$28.69	$83,573.97	175,500
1/4/2023	Ryan J Watts	CEO	Sell	5,029	$28.73	$144,483.17	2,213,464
11/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$30.48	$609,600.00	1,870,356
11/1/2022	Marc Tessier-Lavigne	Director	Sell	8,748	$30.20	$264,189.60	1,901,608
9/28/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$30.82	$616,400.00	1,910,356
8/23/2022	Carole Ho	Insider	Sell	2,424	$31.98	$77,519.52	170,663
8/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$31.61	$632,200.00	1,930,356
8/19/2022	Alexander O Schuth	Insider	Sell	2,576	$33.22	$85,574.72	467,471
8/19/2022	Ryan J Watts	CEO	Sell	2,404	$33.22	$79,860.88	2,202,993
8/19/2022	Steve E Krognes	Director	Sell	2,253	$33.22	$74,844.66	149,468
7/25/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$35.61	$712,200.00	1,950,356
3/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$33.83	$676,600.00
2/11/2022	Alexander O Schuth	COO	Sell	2,803	$34.68	$97,208.04
2/11/2022	Carole Ho	Insider	Sell	2,918	$34.71	$101,283.78
2/11/2022	Ryan J Watts	CEO	Sell	9,491	$34.72	$329,527.52
2/11/2022	Steve E Krognes	CFO	Sell	2,560	$34.69	$88,806.40
2/9/2022	Alexander O Schuth	COO	Sell	1,423	$37.10	$52,793.30
2/9/2022	Ryan J Watts	CEO	Sell	2,719	$37.55	$102,098.45
2/9/2022	Steve E Krognes	CFO	Sell	1,296	$37.09	$48,068.64
1/5/2022	Alexander O Schuth	COO	Sell	2,846	$44.77	$127,415.42
1/5/2022	Carole Ho	Insider	Sell	2,845	$44.78	$127,399.10
1/5/2022	Ryan J Watts	CEO	Sell	5,007	$44.78	$224,213.46
1/5/2022	Steve E Krognes	CFO	Sell	2,225	$44.75	$99,568.75
12/30/2021	Marc Tessier-Lavigne	Director	Sell	20,047	$45.36	$909,331.92
12/28/2021	Marc Tessier-Lavigne	Director	Sell	10,980	$44.37	$487,182.60
12/6/2021	Alexander O Schuth	COO	Sell	10,000	$42.27	$422,700.00
12/6/2021	Carole Ho	Insider	Sell	1,476	$42.52	$62,759.52
12/1/2021	Ryan J Watts	CEO	Sell	18,333	$44.92	$823,518.36
11/10/2021	Vicki L. Sato	Director	Sell	1,666	$52.81	$87,981.46
11/4/2021	Alexander O Schuth	COO	Sell	10,000	$52.84	$528,400.00
10/4/2021	Alexander O Schuth	COO	Sell	10,000	$50.56	$505,600.00
9/15/2021	Vicki L. Sato	Director	Sell	1,666	$53.40	$88,964.40
9/7/2021	Alexander O Schuth	COO	Sell	10,000	$55.55	$555,500.00
9/1/2021	Ryan J. Watts	CEO	Sell	18,333	$54.66	$1,002,081.78
8/23/2021	Carole Ho	Insider	Sell	6,143	$48.91	$300,454.13
8/19/2021	Alexander O Schuth	COO	Sell	2,544	$49.60	$126,182.40
8/19/2021	Carole Ho	Insider	Sell	2,546	$49.58	$126,230.68
8/19/2021	Ryan J Watts	CEO	Sell	2,376	$49.57	$117,778.32
8/19/2021	Steve E. Krognes	CFO	Sell	2,285	$49.57	$113,267.45
8/18/2021	Vicki L. Sato	Director	Sell	1,666	$51.70	$86,132.20
8/4/2021	Alexander O Schuth	COO	Sell	10,000	$52.22	$522,200.00
8/2/2021	Ryan J Watts	CEO	Sell	18,333	$51.41	$942,499.53
7/21/2021	Vicki L. Sato	Director	Sell	1,666	$65.13	$108,506.58
6/23/2021	Vicki L. Sato	Director	Sell	1,666	$70.74	$117,852.84
6/7/2021	Marc Tessier-Lavigne	Director	Sell	94,378	$70.35	$6,639,492.30
6/4/2021	Alexander O. Schuth	COO	Sell	10,000	$64.55	$645,500.00
6/1/2021	Ryan J. Watts	CEO	Sell	18,333	$61.40	$1,125,646.20
5/26/2021	Vicki L. Sato	Director	Sell	1,666	$65.37	$108,906.42
5/24/2021	Marc Tessier-Lavigne	Director	Sell	8,806	$60.02	$528,536.12
5/21/2021	Marc Tessier-Lavigne	Director	Sell	37,957	$60.13	$2,282,354.41
5/4/2021	Alexander O. Schuth	COO	Sell	10,000	$55.49	$554,900.00
4/28/2021	Vicki L. Sato	Director	Sell	1,666	$62.15	$103,541.90

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Denali Therapeutics (NASDAQ:DNLI)

92.92% of Denali Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Denali Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Wasatch Advisors LP	402,670	$8.26M	0.0%	+28.9%	0.289%
4/5/2024	Los Angeles Capital Management LLC	55,612	$1.14M	0.0%	+19.4%	0.040%
3/22/2024	PNC Financial Services Group Inc.	2,486	$53K	0.0%	+48.1%	0.002%
3/11/2024	Vanguard Group Inc.	10,834,483	$232.51M	0.0%	+2.2%	7.786%
3/5/2024	Fisher Asset Management LLC	2,733	$59K	0.0%	N/A	0.002%
3/5/2024	Wellington Management Group LLP	7,274,717	$156.12M	0.0%	-0.2%	5.228%
2/28/2024	University of Texas Texas AM Investment Managment Co.	30,428	$0.65M	0.3%	N/A	0.022%
2/26/2024	Virtu Financial LLC	15,576	$0.33M	0.0%	N/A	0.011%
2/26/2024	Teachers Retirement System of The State of Kentucky	208,644	$4.48M	0.0%	-4.4%	0.150%
2/15/2024	Flagship Pioneering Inc.	2,319,968	$49.79M	3.8%	-11.5%	1.670%
2/15/2024	Gilder Gagnon Howe & Co. LLC	1,219,392	$26.17M	0.4%	-2.2%	0.878%
2/15/2024	Brandywine Managers LLC	9,601	$0.21M	0.2%	N/A	0.007%
2/14/2024	Braidwell LP	461,769	$9.91M	0.4%	N/A	0.332%
2/14/2024	Wasatch Advisors LP	312,301	$6.70M	0.0%	-2.9%	0.225%
2/14/2024	Seven Eight Capital LP	72,587	$1.56M	0.2%	N/A	0.052%
2/14/2024	Sectoral Asset Management Inc.	12,881	$0.28M	0.1%	-94.9%	0.009%
2/13/2024	Capital Research Global Investors	2,909,528	$62.44M	0.0%	+1.0%	2.095%
2/13/2024	Rafferty Asset Management LLC	321,973	$6.91M	0.0%	+40.4%	0.232%
2/13/2024	Campbell & CO Investment Adviser LLC	65,105	$1.40M	0.1%	+277.2%	0.047%
2/12/2024	Crestline Management LP	5,660,732	$121.48M	10.3%	-5.0%	4.076%
2/12/2024	Eagle Asset Management Inc.	315,520	$6.77M	0.0%	+9.1%	0.227%
2/12/2024	Capstone Investment Advisors LLC	22,889	$0.49M	0.0%	-39.1%	0.016%
2/12/2024	TD Asset Management Inc	91,044	$1.95M	0.0%	-32.6%	0.066%
2/12/2024	Edmond DE Rothschild Holding S.A.	165,680	$3.56M	0.1%	+65.9%	0.119%
2/12/2024	Artisan Partners Limited Partnership	383,942	$8.24M	0.0%	-5.6%	0.276%
2/12/2024	Pier 88 Investment Partners LLC	45,240	$0.97M	0.2%	-10.8%	0.033%
2/9/2024	Franklin Resources Inc.	53,201	$1.14M	0.0%	-10.4%	0.038%
2/9/2024	Assetmark Inc.	3,550	$76K	0.0%	+65.3%	0.003%
2/9/2024	Quest Partners LLC	9,965	$0.21M	0.0%	N/A	0.007%
2/9/2024	UBS Group AG	290,985	$6.25M	0.0%	+165.3%	0.210%
2/9/2024	Dynamic Technology Lab Private Ltd	27,429	$0.59M	0.1%	+18.8%	0.020%
2/9/2024	Norges Bank	1,152,646	$24.74M	0.0%	N/A	0.830%
2/8/2024	Pathway Capital Management LP	69,450	$1.49M	1.7%	N/A	0.050%
2/7/2024	Principal Financial Group Inc.	1,073,704	$23.04M	0.0%	+57.9%	0.773%
2/7/2024	Dimensional Fund Advisors LP	1,119,628	$24.03M	0.0%	+15.0%	0.806%
2/7/2024	BNP Paribas Financial Markets	191,643	$4.11M	0.0%	+17.7%	0.138%
2/7/2024	Teacher Retirement System of Texas	25,426	$0.55M	0.0%	-18.2%	0.018%
2/7/2024	E Fund Management Co. Ltd.	17,290	$0.37M	0.0%	+46.8%	0.012%
2/6/2024	Charles Schwab Investment Management Inc.	1,006,997	$21.61M	0.0%	+2.6%	0.725%
2/6/2024	Amalgamated Bank	17,057	$0.37M	0.0%	-6.6%	0.012%
2/6/2024	Swiss National Bank	216,700	$4.65M	0.0%	-10.0%	0.156%
2/6/2024	Fisher Asset Management LLC	2,733	$59K	0.0%	N/A	0.002%
2/5/2024	Victory Capital Management Inc.	15,348	$0.33M	0.0%	+27.0%	0.011%
2/5/2024	Russell Investments Group Ltd.	111,473	$2.39M	0.0%	-2.3%	0.080%
2/2/2024	State of New Jersey Common Pension Fund D	136,600	$2.93M	0.0%	+27.6%	0.098%
2/1/2024	New York State Common Retirement Fund	123,974	$2.66M	0.0%	-4.5%	0.089%
2/1/2024	Handelsbanken Fonder AB	23,900	$0.51M	0.0%	+39.0%	0.017%
2/1/2024	CWM LLC	2,011	$43K	0.0%	+216.7%	0.001%
1/31/2024	abrdn plc	324,829	$6.97M	0.0%	N/A	0.234%
1/31/2024	Knights of Columbus Asset Advisors LLC	77,352	$1.66M	0.1%	+102.9%	0.056%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	22,787	$0.49M	0.0%	+10.2%	0.016%
1/30/2024	VELA Investment Management LLC	26,145	$0.56M	0.2%	+31.4%	0.019%
1/26/2024	Baillie Gifford & Co.	14,260,724	$306.04M	0.2%	-2.9%	10.268%
1/25/2024	Nisa Investment Advisors LLC	66,059	$1.42M	0.0%	+267.8%	0.048%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	73,585	$1.58M	0.0%	+5.6%	0.053%
1/24/2024	China Universal Asset Management Co. Ltd.	15,981	$0.34M	0.1%	+353.2%	0.012%
1/10/2024	Arthur M. Cohen & Associates LLC	10,564	$0.23M	0.1%	-18.4%	0.008%
12/18/2023	Vanguard Group Inc.	10,597,781	$218.63M	0.0%	+3.5%	7.668%
12/13/2023	Teachers Retirement System of The State of Kentucky	218,194	$4.50M	0.0%	-0.6%	0.158%
12/1/2023	Wellington Management Group LLP	7,288,960	$150.37M	0.0%	+3.6%	5.274%
11/16/2023	Ironwood Investment Management LLC	18,096	$0.37M	0.2%	-3.3%	0.013%
11/15/2023	Dana Investment Advisors Inc.	24,629	$0.51M	0.0%	-9.0%	0.018%
11/15/2023	GSA Capital Partners LLP	37,404	$0.77M	0.1%	N/A	0.027%
11/15/2023	Sectoral Asset Management Inc.	254,941	$5.26M	1.0%	+3.9%	0.184%
11/15/2023	Alps Advisors Inc.	101,400	$2.09M	0.0%	+0.8%	0.073%
11/14/2023	Eventide Asset Management LLC	621,850	$12.83M	0.2%	+98.4%	0.450%
11/14/2023	Gotham Asset Management LLC	19,391	$0.40M	0.0%	N/A	0.014%
11/14/2023	Teza Capital Management LLC	21,636	$0.45M	0.0%	N/A	0.016%
11/14/2023	Trexquant Investment LP	42,349	$0.87M	0.0%	-36.7%	0.031%
11/14/2023	Profund Advisors LLC	40,154	$0.83M	0.0%	-13.6%	0.029%
11/13/2023	Eagle Asset Management Inc.	289,133	$5.97M	0.0%	-1.9%	0.209%
11/13/2023	Northern Trust Corp	1,116,742	$23.04M	0.0%	+2.5%	0.808%
11/13/2023	Federated Hermes Inc.	1,351,900	$27.89M	0.1%	+27.1%	0.978%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	20,200	$0.42M	0.0%	N/A	0.015%
11/13/2023	Hsbc Holdings PLC	17,427	$0.36M	0.0%	N/A	0.013%
11/13/2023	FMR LLC	1,058,497	$21.84M	0.0%	-2.0%	0.766%
11/13/2023	Rafferty Asset Management LLC	229,313	$4.73M	0.0%	-7.7%	0.166%
11/13/2023	Baillie Gifford & Co.	14,681,027	$302.87M	0.3%	-1.1%	10.623%
11/13/2023	DekaBank Deutsche Girozentrale	64,210	$1.36M	0.0%	+7.4%	0.046%
11/13/2023	E Fund Management Co. Ltd.	11,781	$0.24M	0.0%	-11.8%	0.009%
11/9/2023	Rhumbline Advisers	169,124	$3.49M	0.0%	+4.4%	0.123%
11/9/2023	Deutsche Bank AG	116,498	$2.40M	0.0%	-19.6%	0.085%
11/9/2023	Citigroup Inc.	138,309	$2.85M	0.0%	+28.0%	0.101%
11/9/2023	Pier 88 Investment Partners LLC	50,700	$1.05M	0.3%	+6.3%	0.037%
11/9/2023	UBS Group AG	109,696	$2.26M	0.0%	-16.9%	0.080%
11/9/2023	Artisan Partners Limited Partnership	406,622	$8.39M	0.0%	-2.4%	0.296%
11/9/2023	Mitsubishi UFJ Trust & Banking Corp	290,960	$6M	0.0%	+0.5%	0.212%
11/8/2023	State of New Jersey Common Pension Fund D	107,089	$2.21M	0.0%	+36.8%	0.078%
11/8/2023	Campbell & CO Investment Adviser LLC	17,258	$0.36M	0.0%	N/A	0.013%
11/8/2023	Charles Schwab Investment Management Inc.	981,059	$20.24M	0.0%	+13.1%	0.714%
11/8/2023	Swiss National Bank	240,800	$4.97M	0.0%	+1.1%	0.175%
11/8/2023	Amalgamated Bank	18,255	$0.38M	0.0%	+3.9%	0.013%
11/7/2023	New York State Common Retirement Fund	129,853	$2.68M	0.0%	+3.1%	0.095%
11/7/2023	VELA Investment Management LLC	19,899	$0.41M	0.2%	-3.7%	0.014%
11/7/2023	Barclays PLC	166,507	$3.44M	0.0%	+5.1%	0.121%
11/7/2023	Jump Financial LLC	19,787	$0.41M	0.0%	N/A	0.014%
11/6/2023	Los Angeles Capital Management LLC	46,002	$0.95M	0.0%	+2.3%	0.033%
11/6/2023	Victory Capital Management Inc.	12,081	$0.25M	0.0%	+5.5%	0.009%
11/4/2023	Capula Management Ltd	38,720	$0.80M	0.0%	N/A	0.028%
11/2/2023	Principal Financial Group Inc.	680,078	$14.03M	0.0%	-0.9%	0.495%

Data available starting January 2016

Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases and lysosomal storage diseases in the United States. The company's transport vehicle (TV)-enabled programs include DNL310 ETV, an IDS enzyme replacement therapy program for MPS II; TAK-594/DNL593 which is in Phase 1/II for frontotemporal dementia-granulin; DNL126 program for MPS IIIA; and DNL622 for MPS I, as well as other preclinical programs that target amyloid beta and HER2. Its brain-penetrant small molecule programs comprise BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; SAR443820/DNL788 RIPK1 inhibitor program for CNS disease; DNL343 eIF2B Activator program for amyotrophic lateral sclerosis; and SAR443122/DNL758 RIPK1 inhibitor program for peripheral inflammatory diseases. It also provides early stage program include TAK-594/DNL593 program for FTD-GRN; DNL126 program for MPS IIIA, a Sanfilippo Syndrome A; DNL622 for MPS I which is Hurler syndrome; Antibody Transport Vehicle Amyloid beta program; Oligonucleotide Transport Vehicle platform, a novel class of biotherapeutics to address the root cause of diseases through modulation of gene expression; and other TV-enabled discovery programs. The company has collaboration agreements with Biogen MA Inc. and Biogen International GmbH; Genzyme Corporation; Takeda Pharmaceutical Company Limited; F-star Gamma Limited, F-star Biotechnologische Forschungs-und Entwicklungsges m.b.H, and F-star Biotechnology Limited; and Genentech, Inc. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.

Today's Range

Now: $14.96

$14.58

$15.25

50 Day Range

MA: $19.10

$15.56

$23.35

52 Week Range

Now: $14.96

$14.56

$33.31

Volume

1,140,416 shs

Average Volume

1,180,445 shs

Market Capitalization

$2.13 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33

Who are the company insiders with the largest holdings of Denali Therapeutics?: Denali Therapeutics' top insider investors include:
Ryan J Watts (CEO)
Marc Tessier-Lavigne (Director)
Alexander O Schuth (Insider)
Carole Ho (Insider)
Steve E Krognes (Director)
Vicki L Sato (Director)
Learn More about top insider investors at Denali Therapeutics.
Who are the major institutional investors of Denali Therapeutics?: Denali Therapeutics' top institutional shareholders include:
Wasatch Advisors LP — 0.29%
Los Angeles Capital Management LLC — 0.04%
Learn More about top institutional investors of Denali Therapeutics stock.
Which major investors are buying Denali Therapeutics stock?: Within the previous quarter, DNLI stock was purchased by institutional investors including:
Wasatch Advisors LP
Los Angeles Capital Management LLC